Developing the 2023 WHO guideline on wasting and nutritional oedema in infants and children: key reflections on
Celeste E Naude1, Michael McCaul1, Kirrily de Polnay2
1Centre for Evidence-based Health Care, Division Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.
Abstract:
The 2023 WHO guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition) in infants and children under 5 years has a broad scope aligned with WHO's responsibility to develop a comprehensive guideline as part of the Global Action Plan on Child Wasting. A WHO technical team consisting of the WHO Steering Committee for this guideline, supported by a consultant and two independent methodologists, coordinated guideline development according to WHO's standards and methods. The guideline contains 21 recommendations and 12 good practice statements on prevention and management across four focus areas. As can be expected from a broad guideline covering many new areas, we faced complexities. As a technical team involved throughout the 3-year process, we reflected on the challenges and our experiences in addressing these. In this paper, we summarise selected elements of processes and methods and our key reflections and learnings relevant to three challenging areas that may be useful to other guideline developers and groups addressing complex needs across contexts. Key reflections included (1) implementing comprehensive and systematic prioritisation was time well spent, allowing the most pressing guidance gaps to be addressed first, while also identifying possible future gaps; (2) evidence syntheses and evidence-to-decision approaches for broad and composite guideline questions required careful planning and coordination, which helped streamline Guideline Development Group discussions and consensus during decision-making and (3) putting steps in place aimed at ensuring consistency and rigour across multiple questions, reviews and meetings improved transparent and systematic guideline development processes.
More Related Videos
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
07:11Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
Published on: February 5, 2019
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Nephrotic Syndrome III : Nursing Management
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Enteral Nutrition I: Orogastric and Nasogastric Feeding
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Nephrotic Syndrome II : Assessment and Medical Management
